Finance

Beta
Lists
185490:KOSDAQ
EyeGene Inc
₩1,480.00
-1.66%
(-25.00) 1D
Jun 5, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 185490...
Open
₩1,520
High
₩1,589
Low
₩1,444
Mkt. cap
63.98B
Avg. vol.
2.70M
Volume
695.32K
52-wk high
₩3,342
52-wk low
₩1,182
EPS
-₩728
Shares outstanding
43.23M
No. of employees
47
Open
₩1,520
High
₩1,589
Low
₩1,444
Mkt. cap
63.98B
Avg. vol.
2.70M
Volume
695.32K
52-wk high
₩3,342
52-wk low
₩1,182
EPS
-₩728
Shares outstanding
43.23M
No. of employees
47
News stories
From sources across the web
About EyeGene Inc
CEOYoo Won-jin
Employees47
Founded2000
Headquarters-
SectorBiotechnology
Websiteeyegene.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
877.31M
1.10B
774.00M
1.27B
Cost of goods sold
603.63M
783.84M
537.77M
930.51M
Cost of revenue
603.63M
783.84M
537.77M
930.51M
Research and development expenses
1.43B
630.81M
2.37B
2.55B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.15B
1.18B
993.56M
1.18B
Operating expense
2.73B
1.96B
3.57B
3.87B
Total operating expenses
3.33B
2.75B
4.11B
4.80B
Operating income
-2.45B
-1.65B
-3.34B
-3.53B
Other non operating income
-316.96M
306.00M
654.22M
205.88M
EBT including unusual items
-2.46B
-1.57B
-12.06B
-3.56B
EBT excluding unusual items
-2.59B
-1.57B
-2.65B
-3.56B
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
27.57M
39.30M
15.05M
32.93M
Net income
-2.42B
-1.52B
-8.83B
-3.45B
Net profit margin
-275.55%
-138.08%
-1,141.38%
-271.35%
Earnings per share
-
-
-
-
Interest and investment income
200.17M
-
146.65M
-
Interest expense
-
-174.26M
-105.75M
-
Net interest expenses
200.17M
-174.26M
40.90M
-
Depreciation and amortization charges
110.70M
110.75M
107.08M
102.26M
EBITDA
-1.92B
-1.14B
-2.84B
-3.01B
Gain or loss from assets sale
681.96M
12.38M
152.26M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer